The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Try the newly designed Company Pages!
Switch now

Johnson & Johnson

  • JNJ
  • NYSE
  • Consumer Products
  • Latest 103.13
  • Currency US$
  • Change 0.50
  • Percent Change 0.487 %
  • Volume 5,973,142
  • Fri Oct 24, 2014 04:00 PM EDT NYSE data delayed 15 minutes.
  • Open 102.95
  • Previous Close 102.63
  • High 103.29
  • Low 102.206
  • Bidx1 102.94
  • Askx2 103.25
  • 52-week High09/24 108.77
  • 52-week Low02/04 86.09
  • Beta 0.643
  • Market Cap 291,684.65M
  • EPS 5.94
  • P/E 17.362
  • Forward P/E 16.66
  • PEG 2.74
  • Annual Dividend 2.80
  • Yield 2.715

News

Financials & Calendars

Income Statement

  • Sales $71,922,000,000
  • Earnings $15,061,000,000
  • Return on Equity 20.00%

Cash Flow

  • Cash Flow --
  • Cash $19,722,000,000
  • Current Ratio 2.41

12 months ended Mar 31, 2014.

Trailing 12 month results shown above.
All data is in U.S. dollars.

Balance Sheet

  • Assets $133,330,000,000
  • Liabilities $56,748,000,000
  • Liabilities-to-Equity Ratio 0.74

Price Ratios

  • Price to Sales 4.06
  • Price to Book 3.81
  • Price to Cash Flow n/a

Event Calendar

Event Last   Next  
Earnings Oct 14 $1.42 Jan 20 $1.25
Surprises Oct 14 5.63% n/a n/a
Dividends Aug 22 $0.70 Nov 21 $0.70
Splits n/a -- n/a n/a

12 months ended Oct 24, 2014.

A look at major corporate events and financial announcements that are coming up.

Company Information

About the Company

Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.

Related Securities
Symbol Type Latest % Chg

Officers

  • A. Gorsky Chairman&Chief Executive Offic
  • D. J. Caruso Chief Financial Officer
  • Company Type: n/a
  • Company Status: n/a
  • Full-time Employees: n/a
  • Incorporation: United States,
    n/a
  • Top 1000 Ranking: Profit: n/a
    Revenue: n/a
    Assets: n/a

Head Office

ONE JOHNSON & JOHNSON PLZ
NEW BRUNSWICK, NJ
08933

Phone: (732)-524-2455
Fax: (732)-2140332


www.jnj.com

Ideas & Discussion

Live Discussion of JNJ on StockTwits
The Globe and Mail has
updated our Company Pages
Switch to the newly designed Company Pages format today for a more in-depth look at the companies you're following and pages that are easier to navigate. If you prefer the old layout after trying the new Company Pages, you can switch back anytime.